Carstens P-O, Schmidt J
Clinic for Neurology, University Medical Centre Göttingen, Göttingen, Germany.
Clin Exp Immunol. 2014 Mar;175(3):349-58. doi: 10.1111/cei.12194.
Dermatomyositis (DM), polymyositis (PM), necrotizing myopathy (NM) and inclusion body myositis (IBM) are four distinct subtypes of idiopathic inflammatory myopathies - in short myositis. Recent studies have shed some light on the unique pathogenesis of each entity. Some of the clinical features are distinct, but muscle biopsy is indispensable for making a reliable diagnosis. The use of magnetic resonance imaging of skeletal muscles and detection of myositis-specific autoantibodies have become useful additions to our diagnostic repertoire. Only few controlled trials are available to substantiate current treatment approaches for myositis and hopes are high that novel modalities will become available within the next few years. In this review we provide an up-to-date overview of the pathogenesis and diagnostic approach of myositis. We aim to present a guide towards therapeutic and general management.
皮肌炎(DM)、多发性肌炎(PM)、坏死性肌病(NM)和包涵体肌炎(IBM)是特发性炎性肌病(简称为肌炎)的四种不同亚型。最近的研究对每种疾病独特的发病机制有了一些了解。某些临床特征有所不同,但肌肉活检对于做出可靠诊断必不可少。骨骼肌磁共振成像的应用以及肌炎特异性自身抗体的检测已成为我们诊断方法中的有用补充。仅有少数对照试验可证实目前针对肌炎的治疗方法,人们寄厚望于在未来几年内会有新的治疗方式出现。在本综述中,我们提供了肌炎发病机制和诊断方法的最新概述。我们旨在给出一份治疗及综合管理指南。